NCT00596479View on ClinicalTrials.gov

Filgrastim for the Promotion of Collateral Growth in Patients With CAD

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

November 30, 2004

Primary Completion Date

December 31, 2007

Study Completion Date

December 31, 2007

Conditions
Coronary Artery Disease
Interventions
DRUG

Filgrastim (rG-CSF)

Trial Locations (1)

3010

University Hospital Bern, Bern

All Listed Sponsors
collaborator

Swiss National Science Foundation

OTHER

collaborator

Swiss Heart Foundation

OTHER

lead

Insel Gruppe AG, University Hospital Bern

OTHER

NCT00596479 - Filgrastim for the Promotion of Collateral Growth in Patients With CAD | Biotech Hunter | Biotech Hunter